Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1414 participants.
Also called NCT03112980
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,414 participants
- Registry
-
NCT03112980
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03112980. Randomized; no masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
- Acronym
- DEDICATE
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Transcatheter aortic valve implantation
- Intervention (Procedure)
- Surgical aortic valve replacement
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator
- The German Heart Foundation
Record details
- Record id
cardio:ct-nct03112980- Content hash
9643427c2bca3f4bffd3989d39155d1ff63f0028cb62e13f30942d46fd9ba7a5